Premium
MeiraGTx Holdings PLC (MGTX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and Eu... MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union. Show more
LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the U.S...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -0.809061488673 | 6.18 | 6.595 | 6.08 | 206114 | 6.29801394 | CS |
| 4 | -0.18 | -2.85261489699 | 6.31 | 6.66 | 5.6 | 305749 | 6.16733875 | CS |
| 12 | -0.96 | -13.5401974612 | 7.09 | 7.37 | 5.6 | 273833 | 6.21906733 | CS |
| 26 | 1.63 | 36.2222222222 | 4.5 | 7.37 | 3.85 | 271524 | 5.59852545 | CS |
| 52 | 0.34 | 5.87219343696 | 5.79 | 7.37 | 3.85 | 218576 | 5.47442744 | CS |
| 156 | -7.52 | -55.0915750916 | 13.65 | 15.87 | 3.49 | 195650 | 6.48818756 | CS |
| 260 | -13.58 | -68.8990360223 | 19.71 | 24.8948 | 3.49 | 178449 | 9.84845016 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
